Radiopharmaceuticals and Immunotherapeutics

from our


based on


(Single domain antibodies or VHHs)

“Nanobody” is a registered trademark of Ablynx NV, Sanofi


Cortalix is a clinical-stage biopharmaceutical company capable of developing ImmunoPET, targeted ImmunoRT and Immunotherapeutics for novel targets, based on its proprietary nanobody (single-domain antibody or VHH) discovery platform, which includes multiple synthetic nanobody libraries.

Cortalix operates on the basis of a business model consisting of three pillars:

1: Internal programs

Cortalix has a growing number of Internal Programs of selected nanobody clinical candidates targeting PDGFRA, PDGFRB, FAP, IGF2R, and EGFR for ImmunoPET, ImmunoRT and Immunotherapy in fibrosis and fibrotic cancers. These programs are available for licensing.

2: Partner programs

Cortalix works with pharmaceutical companies and academic research groups in partner programs to screen and select suitable nanobody candidates for novel targets using the synthetic nanobody discovery platform. We can develop these nanobodies in close collaboration into fully-fledged radiopharmaceuticals and immunotherapeutic applications. We can connect our selected, characterized and functionalized nanobodies seamlessly to parties in the downstream process, such as a research cell bank in Pichia pastoris to CDMOs involved in GMP production.

3: Services

We also offer stand-alone nanobody selection and development projects on a fee-for-service basis for CROs, pharma companies and research groups for very different applications, including targeted therapy, immunotherapy, but also for research tools and bioanalytical applications such as immunohistochemistry, fluorescence imaging, tailored affinity columns, and ELISA development and validation.

Latest open positions

VP Business Development

Job description: VP Business Development.Type: 40% – 60%.Location: Innolab Agrifood, Groningen, The Netherlands.Date: Immediate.About the role At Cortalix, The VP Business Development is responsible for managing and developing Cortalix’s business development towards...

read more

Latest news and events


If you would like to know more about our organization, or would like to know how we can support your projects, please complete the contact form. We will contact you shortly.